Merck KGaA investing €1B at headquarters site as part of 5-year work agreement

Merck kgaa
Merck KGaA has reached a new five-year agreement with 11,000 employees who work in and around its Darmstadt, Germany, headquarters site. (Merck KGaA)

Merck KGaA’s headquarters site in Darmstadt, Germany, is the pride of its international operations, and it intends to keep it that way. The German drug and materials maker says it has nailed down new work agreements with employees there and will invest €1 billion in the site.

Merck today said that the company management and the Joint Works Council at Darmstadt have signed a comprehensive agreement covering the 11,000 employees to secure its “future viability.” Merck said that with the deal, workers have bought into changes the company wants to make in its businesses. The agreement extends through 2025.

“With our investment commitment, we are permitting additional growth and are creating employment perspectives for tomorrow and beyond,” Kai Beckmann, the CEO of Performance Materials and the board member in charge of the Darmstadt site said in a statement. “Together with the employee representatives, we want to support the changes in our three business sectors here at the Darmstadt site in the best possible way.”

Free Webinar

Striving for Zero in Quality & Manufacturing

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. This webinar will discuss the role that content management plays in pharmaceutical manufacturing to help companies reach the goal of zero in Quality and Manufacturing.

RELATED: Merck KGaA picks winners and losers as it streamlines EU production network, cutting 200 jobs

Michael Fletterich, chairman of the Works Council of Merck KGaA, said the two sides conducted intensive negotiations “and in some cases had strong debates” but that the agreement was both good for workers and the future of the company.

While €1 billion will be spent on projects and efforts across the site, some of the money will go towards a new plant to build membranes that among other uses go into filters for pharmaceutical production. Some also will be spent on a new Vocational and Advanced Training Center at the site. It said it currently has more than 500 apprentices in 22 vocational training occupations to feed its constant need for trained employees.

The work agreement covers 11,00 employees at Darmstadt and nearby Weiterstadt and Gernsheim in Germany. No employee cuts were announced but the company said it includes “a voluntary leave program and a bridge model for an early transition to retirement.”

The company last fall made some moves that cost 200 manufacturing jobs in Europe but benefited some sites, including Darmstadt.

Read more on

Suggested Articles

The cleaning procedures are so poor at a Zydus Cadila plant in India that the FDA says a sampling found 10 different cross-contaminated products.

Oklahoma politicians contend J&J should be on the line for future abatement costs even after a $572 million verdict, but J&J sees things differently.

Abbott helmsman Miles White, who oversaw the spinoffs of AbbVie and Hospira, will step down as CEO after 21 years at the top job.